Omicron: NCBS monitoring situation in four top cities

03-12-2021 Fri 18:04 IST | IANS | National
Omicron: NCBS monitoring situation in four top cities

Hyderabad Dec 3:  The National Centre for Biological Sciences (NCBS), which confirmed the first two cases of the Omicron variant in Bengaluru on Thursday, is continuously monitoring the situation in four cities - Bengaluru, Hyderabad, New Delhi, and Pune.

The NCBS is a part of a consortium of national laboratories performing genomic surveillance across four city clusters.

The consortium was established four months ago with support from The Rockefeller Foundation's Pandemic Prevention Institute, and is led by the Centre for Cellular and Molecular Biology (CCMB) in Hyderabad.

Dr Rakesh Mishra at the CCMB said on Friday that the consortium is continuously monitoring the situation in all the four cities and has upscaled its efforts to sequence as many samples as possible

Apart from the CCMB and the NCBS, the consortium includes CSIR-Institute of Genomics and Integrative Biology - IGIB in New Delhi and the Pune Knowledge Cluster, Indian Institute of Science Education and Research (IISER), Pune, and CSIR-National Chemical Laboratory in Pune.

The consortium is focused on upscaling genomic surveillance as part of national efforts led by the INSACOG - Indian SARS-CoV-2 Genomics Consortium - to respond to the Covid-19 pandemic. The consortium intensified its sequencing efforts after the World Health Organisation announced Omicron as a Variant of Concern.

Such an intensified effort enabled the Bengaluru team at the NCBS, a member laboratory of INSACOG, in collaboration with Strand Life Sciences and the Bruhat Bengaluru Mahanagara Palike (BBMP), to detect, rapidly sequence and verify the existence of the omicron variant in samples from two Covid-19 infected individuals.

They hope this will aid in a rapid response to contain the spread of variants of concern. Prof Satyajit Mayor from the NCBS conveyed the information to local and national authorities, and the Indian government released a statement on December 2, all within four days of receiving the samples.

Both SARS-CoV-2 genomes have also been uploaded to the global repository for SARS-CoV-2 sequences, GISAID, so that they can be publicly available to the scientific community, the NCBS said.


More News
Biophore receives sub-license to manufacture Molnupiravir
24 minutes ago
Hyderabad techie ends life with wife, daughter
41 minutes ago
Andhra woman kills husband, carries severed head to police station
1 hour ago
Hindi version of 'Pushpa' director's 'Rangasthalam' set for Feb release
2 hours ago
Andhra CM roots for 'One district, One airport' concept
2 hours ago
Andhra's active Covid cases surge to over 53K
2 hours ago
Ganguly wanted to issue show cause notice to Kohli after his press conference outburst: Report
4 hours ago
New film studio to be built in space by 2024
4 hours ago
Australian Open: Sania Mirza-Rajeev Ram advance to mixed doubles second round
5 hours ago
Dolo pill breaks sales record in pandemic as manufacturer makes a fortune
5 hours ago
PM to unveil 216-ft 'Statue of Equality' in Hyd on Feb 5
5 hours ago
Covid booster dose provides good antibody protection against Omicron: Lancet
5 hours ago
A murder mystery unearthing the dark world of Bollywood
5 hours ago
No place for discrimination in India, says PM Modi
7 hours ago
Rs 7,411 cr deposited in Telangana farmers' bank accounts
7 hours ago
Lakshmi Manchu urges Telangana govt to institutionalise digital education
7 hours ago
Sharma, Pant and Ashwin included in ICC Men's Test Team of the Year
7 hours ago
IND vs SA, 2nd ODI: With series on the line, India hope to put up better batting show
8 hours ago
Balakrishna's 'Akhanda' completes 50 days in theatres successfully
9 hours ago
Meera Jasmine opens Instagram account, posts still from comeback movie 'Makal'
9 hours ago